Medicine
Moxifloxacin 400 mg tablet
Moxifloxacin 400 mg tablet is a generic prescription medicine for oral use, made by 16 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15–30°C (59–86°F).
Key facts
- Active ingredient (INN)
- Moxifloxacin
- Brand
- Sold under the generic name
- Strength
- 400 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 50 blister pack, 1000 tablets and 36 more
- Manufacturers
- Dr. Reddy's LaboratoriesIndiaAurobindo PharmaIndiaNovadoz PharmaceuticalsIndiaCamber PharmaceuticalsIndiaMacleods PharmaceuticalsIndiaBryant Ranch PrepackPD-Rx PharmaceuticalsA-S Medication SolutionsRemedyrepackMajor Pharmaceuticals16 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15–30°C (59–86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01MA14 Moxifloxacin
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 4 March 2014
- Identifiers
- RxCUI 311787DailyMed set ID 5c2a9116-d6e4-429e-88bb-bb6bfedac2f0, 71b02da1-3175-1db8-192a-c0a8a6cd98a5, d6789c17-4a2f-4519-9060-e3b0dba422f0 +23NDC 72789-080, 55111-112, 65862-603 +23Application ANDA208682, ANDA076938, ANDA202632 +4
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, film coated in 1 bottle | 65862-603-30 | Aurobindo PharmaIndia | 4 March 2014 |
| 50 blister pack in 1 box, unit-dose / 1 tablet, film coated in 1 blister pack | 65862-603-55 | Aurobindo PharmaIndia | 4 March 2014 |
| 1000 tablet, film coated in 1 bottle | 65862-603-99 | Aurobindo PharmaIndia | 4 March 2014 |
| 500 tablet, film coated in 1 bottle | 31722-845-05 | Camber PharmaceuticalsIndia | 2 March 2023 |
| 30 tablet, film coated in 1 bottle | 31722-845-30 | Camber PharmaceuticalsIndia | 2 March 2023 |
| 100 tablet, film coated in 1 bottle | 55111-112-01 | Dr. Reddy's LaboratoriesIndia | 5 March 2014 |
| 500 tablet, film coated in 1 bottle | 55111-112-05 | Dr. Reddy's LaboratoriesIndia | 5 March 2014 |
| 30 tablet, film coated in 1 bottle | 55111-112-30 | Dr. Reddy's LaboratoriesIndia | 5 March 2014 |
| 5 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 55111-112-66 | Dr. Reddy's LaboratoriesIndia | 5 March 2014 |
| 30 tablet, film coated in 1 bottle | 33342-322-07 | Macleods PharmaceuticalsIndia | 2 March 2026 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 33342-322-12 | Macleods PharmaceuticalsIndia | 2 March 2026 |
| 500 tablet, film coated in 1 bottle | 72205-001-05 | Novadoz PharmaceuticalsIndia | 16 April 2019 |
| 30 tablet, film coated in 1 bottle | 72205-001-30 | Novadoz PharmaceuticalsIndia | 16 April 2019 |
| 50 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 72205-001-31 | Novadoz PharmaceuticalsIndia | 16 April 2019 |
| 30 tablet, film coated in 1 bottle | 62135-014-30 | Chartwell RX | 11 August 2026 |
| 30 tablet, film coated in 1 bottle | 57237-156-30 | Rising Pharma Holdings | 4 March 2014 |
| 30 tablet, film coated in 1 bottle, plastic | 73473-903-30 | Solaris Pharma | 12 December 2025 |
| 10 tablet, film coated in 1 bottle, plastic | 72789-037-10 | PD-Rx Pharmaceuticals | 17 February 2020 |
| 10 tablet, film coated in 1 bottle, plastic | 72789-038-10 | PD-Rx Pharmaceuticals | 10 December 2019 |
| 10 tablet, film coated in 1 bottle, plastic | 72789-080-10 | PD-Rx Pharmaceuticals | 10 April 2020 |
| 10 tablet, film coated in 1 bottle, plastic | 72789-233-10 | PD-Rx Pharmaceuticals | 15 February 2022 |
| 10 tablet, film coated in 1 bottle, plastic | 72789-350-10 | PD-Rx Pharmaceuticals | 15 September 2023 |
| 10 tablet, film coated in 1 bottle | 50090-6609-0 | A-S Medication Solutions | 23 August 2023 |
| 7 tablet, film coated in 1 bottle | 50090-6609-1 | A-S Medication Solutions | 31 October 2023 |
| 7 tablet, film coated in 1 bottle | 50090-7244-1 | A-S Medication Solutions | 13 September 2024 |
| 30 tablet, film coated in 1 bottle | 50090-7665-0 | A-S Medication Solutions | 1 October 2025 |
| 7 tablet, film coated in 1 bottle | 63629-8357-1 | Bryant Ranch Prepack | 17 September 2020 |
| 10 tablet, film coated in 1 bottle | 63629-8357-2 | Bryant Ranch Prepack | 5 November 2020 |
| 7 tablet, film coated in 1 bottle | 71335-2329-1 | Bryant Ranch Prepack | 4 October 2024 |
| 10 tablet, film coated in 1 bottle | 71335-2329-2 | Bryant Ranch Prepack | 3 January 2024 |
| 7 tablet, film coated in 1 bottle | 71335-2815-1 | Bryant Ranch Prepack | 15 October 2025 |
| 10 tablet, film coated in 1 bottle | 71335-2815-2 | Bryant Ranch Prepack | 15 October 2025 |
| 7 tablet, film coated in 1 bottle, plastic | 70518-3738-0 | Remedyrepack | 30 May 2023 |
| 7 tablet, film coated in 1 bottle, plastic | 70518-4312-0 | Remedyrepack | 18 March 2025 |
| 7 tablet, film coated in 1 bottle, plastic | 70518-4458-0 | Remedyrepack | 27 August 2025 |
| 50 blister pack in 1 box, unit-dose / 1 tablet, film coated in 1 blister pack | 68084-722-65 | American Health Packaging | 19 March 2014 |
| 30 blister pack in 1 box, unit-dose / 1 tablet, film coated in 1 blister pack | 50268-576-13 | AvPAK | 22 July 2016 |
| 30 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack | 0904-7407-04 | Major Pharmaceuticals | 8 March 2024 |
| 50 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack | 0904-7407-06 | Major Pharmaceuticals | 8 March 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 10 December 1999 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Moxifloxacin
Clinical summary
Moxifloxacin is a fluoroquinolone antibacterial indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of organisms. It is available as eye drops, tablets and injection for ophthalmic, oral and intravenous use. MedsAcross supplies Moxifloxacin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MoxifloxacinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- VIGAMOX prescribing information (Harrow Eye) · U.S. National Library of Medicine, DailyMed
Need Moxifloxacin 400 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.